Nuclear Medicine Radiopharmaceuticals Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

The Nuclear Medicine Radiopharmaceuticals Market size was valued at US$ 12.09 Billion in 2025 and is projected to reach US$ 52.79 Billion by 2033, growing at a CAGR of 20.23% from 2026 to 2033, driven by cancer diagnosis demand, targeted therapies, nuclear medicine infrastructure expansion, precision oncology adoption, and radiopharmaceutical manufacturing investments.

Report Coverage

Type: Diagnostics, Therapeutics
Application: Neurology, Cardiology, Oncology, Others
End-user: Hospitals & Clinics, Diagnostic Centers, Others

US$ 12.09 Bn Market size in 2025

US$ 52.79 Bn Market Size by 2033

20.23% CAGR, 2026 - 2033

2026-2033 Forecast Period

Download Sample PDF Buy Now

Format PDF + Excel + PPT

No. of Pages: 350

Category Life Sciences

Report Code: BMIPUB00037188

Last Updated: 2026-08-25

Author

Krishna Sunthwal

Analyst Connect

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Nuclear Medicine Radiopharmaceuticals Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Nuclear Medicine Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Nuclear Medicine Radiopharmaceuticals Market Global Analysis

6.2 Nuclear Medicine Radiopharmaceuticals Market Revenue 2022-2033 (US$ Billion)

6.3 Nuclear Medicine Radiopharmaceuticals Market Forecast Analysis

7. Nuclear Medicine Radiopharmaceuticals Market Analysis – by Type

7.1 Diagnostics

7.1.1 Overview
7.1.2 Diagnostics: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.2 Therapeutics

7.2.1 Overview
7.2.2 Therapeutics : Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8. Nuclear Medicine Radiopharmaceuticals Market Analysis – by Application

8.1 Neurology

8.1.1 Overview
8.1.2 Neurology: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.2 Cardiology

8.2.1 Overview
8.2.2 Cardiology: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.3 Oncology

8.3.1 Overview
8.3.2 Oncology: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.4 Others

8.4.1 Overview
8.4.2 Others: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9. Nuclear Medicine Radiopharmaceuticals Market Analysis – by End-user

9.1 Hospitals & Clinics

9.1.1 Overview
9.1.2 Hospitals & Clinics: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.2 Diagnostic Centers

9.2.1 Overview
9.2.2 Diagnostic Centers: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.3 Others

9.3.1 Overview
9.3.2 Others: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10. Nuclear Medicine Radiopharmaceuticals Market – Geographic Analysis

10.1 Overview

10.2 North America

10.2.1 Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Key Country, 2026 and 2033 (%)
10.2.1.1 Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.2.1.1.1 US: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.2.1.1.2 US: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.2.1.1.3 US: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.2.1.2 Canada: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.2.1.2.1 Canada: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.2.1.2.2 Canada: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.2.1.2.3 Canada: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.2.1.3 Mexico : Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.2.1.3.1 Mexico : Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.2.1.3.2 Mexico : Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.2.1.3.3 Mexico : Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3 Europe

10.3.1 Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Key Country, 2026 and 2033 (%)
10.3.1.1 Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
10.3.1.1 Germany: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.1.1 Germany: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.1.2 Germany: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.1.3 Germany: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.2 Italy: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.2.1 Italy: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.2.2 Italy: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.2.3 Italy: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.3 France: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.3.1 France: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.3.2 France: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.3.3 France: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.4 U.K.: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.4.1 U.K.: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.4.2 U.K.: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.4.3 U.K.: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.5 Spain: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.5.1 Spain: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.5.2 Spain: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.5.3 Spain: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.6 Belgium: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.6.1 Belgium: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.6.2 Belgium: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.6.3 Belgium: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.7 Netherlands: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.7.1 Netherlands: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.7.2 Netherlands: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.7.3 Netherlands: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.8 Luxembourg: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.8.1 Luxembourg: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.8.2 Luxembourg: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.8.3 Luxembourg: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.9 Norway: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.9.1 Norway: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.9.2 Norway: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.9.3 Norway: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.10 Finland: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.10.1 Finland: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.10.2 Finland: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.10.3 Finland: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.11 Denmark: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.11.1 Denmark: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.11.2 Denmark: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.11.3 Denmark: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.12 Sweden: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.12.1 Sweden: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.12.2 Sweden: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.12.3 Sweden: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.13 Switzerland: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.13.1 Switzerland: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.13.2 Switzerland: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.13.3 Switzerland: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.14 Austria: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.14.1 Austria: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.14.2 Austria: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.14.3 Austria: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.15 Greece: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.15.1 Greece: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.15.2 Greece: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.15.3 Greece: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.16 Portugal: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.16.1 Portugal: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.16.2 Portugal: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.16.3 Portugal: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.17 Russia: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.17.1 Russia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.17.2 Russia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.17.3 Russia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.18 Poland: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.18.1 Poland: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.18.2 Poland: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.18.3 Poland: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.19 Romania: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.19.1 Romania: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.19.2 Romania: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.19.3 Romania: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.20 Czech Republic: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.20.1 Czech Republic: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.20.2 Czech Republic: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.20.3 Czech Republic: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.21 Ukraine: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.21.1 Ukraine: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.21.2 Ukraine: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.21.3 Ukraine: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.22 Slovakia: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.22.1 Slovakia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.22.2 Slovakia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.22.3 Slovakia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.3.1.23 Bulgaria : Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.23.1 Bulgaria : Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.3.1.23.2 Bulgaria : Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.3.1.23.3 Bulgaria : Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.4 Asia-Pacific

10.4.1 Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Key Country, 2026 and 2033 (%)
10.4.1.1 Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
10.4.1.1 China: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.1.1 China: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.4.1.1.2 China: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.4.1.1.3 China: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.4.1.2 Japan: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.2.1 Japan: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.4.1.2.2 Japan: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.4.1.2.3 Japan: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.4.1.3 South Korea: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.3.1 South Korea: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.4.1.3.2 South Korea: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.4.1.3.3 South Korea: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.4.1.4 India: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.4.1 India: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.4.1.4.2 India: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.4.1.4.3 India: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.4.1.5 Australia: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.5.1 Australia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.4.1.5.2 Australia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.4.1.5.3 Australia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.4.1.6 New Zealand: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.6.1 New Zealand: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.4.1.6.2 New Zealand: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.4.1.6.3 New Zealand: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.4.1.7 Indonesia: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.7.1 Indonesia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.4.1.7.2 Indonesia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.4.1.7.3 Indonesia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.4.1.8 Malaysia: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.8.1 Malaysia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.4.1.8.2 Malaysia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.4.1.8.3 Malaysia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.4.1.9 Philippines: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.9.1 Philippines: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.4.1.9.2 Philippines: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.4.1.9.3 Philippines: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.4.1.10 Singapore: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.10.1 Singapore: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.4.1.10.2 Singapore: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.4.1.10.3 Singapore: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.4.1.11 Thailand: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.11.1 Thailand: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.4.1.11.2 Thailand: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.4.1.11.3 Thailand: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.4.1.12 Vietnam: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.12.1 Vietnam: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.4.1.12.2 Vietnam: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.4.1.12.3 Vietnam: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.4.1.13 Taiwan: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.13.1 Taiwan: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.4.1.13.2 Taiwan: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.4.1.13.3 Taiwan: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.4.1.14 Bangladesh : Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.14.1 Bangladesh : Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.4.1.14.2 Bangladesh : Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.4.1.14.3 Bangladesh : Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.5 South and Central America

10.5.1 Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Key Country, 2026 and 2033 (%)
10.5.1.1 Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
10.5.1.1 Brazil: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.1.1 Brazil: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.5.1.1.2 Brazil: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.5.1.1.3 Brazil: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.5.1.2 Argentina: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.2.1 Argentina: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.5.1.2.2 Argentina: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.5.1.2.3 Argentina: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.5.1.3 Chile: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.3.1 Chile: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.5.1.3.2 Chile: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.5.1.3.3 Chile: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.5.1.4 Colombia: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.4.1 Colombia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.5.1.4.2 Colombia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.5.1.4.3 Colombia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.5.1.5 Peru : Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.5.1 Peru : Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.5.1.5.2 Peru : Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.5.1.5.3 Peru : Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.6 Middle East and Africa

10.6.1 Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Key Country, 2026 and 2033 (%)
10.6.1.1 Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
10.6.1.1 Saudi Arabia: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.1.1 Saudi Arabia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.6.1.1.2 Saudi Arabia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.6.1.1.3 Saudi Arabia: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.6.1.2 United Arab Emirates: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.2.1 United Arab Emirates: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.6.1.2.2 United Arab Emirates: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.6.1.2.3 United Arab Emirates: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.6.1.3 Kuwait: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.3.1 Kuwait: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.6.1.3.2 Kuwait: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.6.1.3.3 Kuwait: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.6.1.4 Bahrain: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.4.1 Bahrain: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.6.1.4.2 Bahrain: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.6.1.4.3 Bahrain: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.6.1.5 Qatar: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.5.1 Qatar: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.6.1.5.2 Qatar: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.6.1.5.3 Qatar: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.6.1.6 Oman: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.6.1 Oman: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.6.1.6.2 Oman: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.6.1.6.3 Oman: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.6.1.7 Turkiye: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.7.1 Turkiye: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.6.1.7.2 Turkiye: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.6.1.7.3 Turkiye: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.6.1.8 South Africa: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.8.1 South Africa: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.6.1.8.2 South Africa: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.6.1.8.3 South Africa: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.6.1.9 Egypt: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.9.1 Egypt: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.6.1.9.2 Egypt: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.6.1.9.3 Egypt: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.6.1.10 Nigeria: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.10.1 Nigeria: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.6.1.10.2 Nigeria: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.6.1.10.3 Nigeria: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

10.6.1.11 Algeria: Nuclear Medicine Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.11.1 Algeria: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Type
10.6.1.11.2 Algeria: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by Application
10.6.1.11.3 Algeria: Nuclear Medicine Radiopharmaceuticals Market Breakdown, by End-user

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Curium Pharma

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 GE HealthCare

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Cardinal Health, Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Lantheus Holdings, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Novartis AG

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Bracco Imaging S.p.A.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Bayer AG

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Eckert & Ziegler SE

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Jubilant Radiopharma

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Telix Pharmaceuticals Limited

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Access the Full N Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization